FilingSEC EDGARS-1
BioStem Technologies Enters into $40 Million Committed Equity Facility
· SEC accepted
StageAgreement Signed
Filing content
The company entered into a $40 million common stock purchase agreement with Roth Principal Investments and registered 12.05 million shares for potential resale.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…